Piper Sandler Maintains Neutral on Edwards Lifesciences, Lowers Price Target to $73
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Adam Maeder maintains a Neutral rating on Edwards Lifesciences (NYSE:EW) and lowers the price target from $88 to $73.
July 25, 2024 | 12:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Piper Sandler analyst Adam Maeder maintains a Neutral rating on Edwards Lifesciences and lowers the price target from $88 to $73.
The lowered price target from $88 to $73 by Piper Sandler suggests a less optimistic outlook for Edwards Lifesciences, which could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100